Flow cytometry quality requirements for monitoring of minimal disease in plasma cell myeloma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Flow cytometry quality requirements for monitoring of minimal disease in plasma cell myeloma
Authors
Keywords
-
Journal
CYTOMETRY PART B-CLINICAL CYTOMETRY
Volume 90, Issue 1, Pages 40-46
Publisher
Wiley
Online
2015-07-23
DOI
10.1002/cyto.b.21276
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Flow cytometry detection of minimal residual disease in multiple myeloma: Lessons learned at FDA-NCI roundtable symposium
- (2014) Ola Landgren et al. AMERICAN JOURNAL OF HEMATOLOGY
- Front-Line Transplantation Program With Lenalidomide, Bortezomib, and Dexamethasone Combination As Induction and Consolidation Followed by Lenalidomide Maintenance in Patients With Multiple Myeloma: A Phase II Study by the Intergroupe Francophone du Myélome
- (2014) Murielle Roussel et al. JOURNAL OF CLINICAL ONCOLOGY
- Minimal residual disease testing in multiple myeloma by flow cytometry: major heterogeneity
- (2013) A. Flanders et al. BLOOD
- Clinical applicability and prognostic significance of molecular response assessed by fluorescent-PCR of immunoglobulin genes in multiple myeloma. Results from a GEM/PETHEMA study
- (2013) Joaquin Martinez-Lopez et al. BRITISH JOURNAL OF HAEMATOLOGY
- Validation of cell-based fluorescence assays: Practice guidelines from the ICSH and ICCS - part I - rationale and aims
- (2013) Bruce H. Davis et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Validation of cell-based fluorescence assays: Practice guidelines from the ICSH and ICCS - part IV - postanalytic considerations
- (2013) David Barnett et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Validation of cell-based fluorescence assays: Practice guidelines from the ICSH and ICCS - part III - analytical issues
- (2013) Shabnam Tanqri et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Validation of cell-based fluorescence assays: Practice guidelines from the ICSH and ICCS - part V - assay performance criteria
- (2013) Brent Wood et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study
- (2013) Andy C. Rawstron et al. JOURNAL OF CLINICAL ONCOLOGY
- Association of response endpoints with survival outcomes in multiple myeloma
- (2013) S Lonial et al. LEUKEMIA
- How should we treat newly diagnosed multiple myeloma patients?
- (2013) M.-V. Mateos et al. Hematology-American Society of Hematology Education Program
- Multiparameter Flow Cytometry Evaluation of Plasma Cell DNA Content and Proliferation in 595 Transplant-Eligible Patients with Myeloma Included in the Spanish GEM2000 and GEM2005
- (2012) Bruno Paiva et al. AMERICAN JOURNAL OF PATHOLOGY
- Characterization of potential CD138 negative myeloma "stem cells"
- (2012) J. H. Christensen et al. HAEMATOLOGICA
- High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma
- (2011) B. Paiva et al. BLOOD
- Comparison of Immunofixation, Serum Free Light Chain, and Immunophenotyping for Response Evaluation and Prognostication in Multiple Myeloma
- (2011) Bruno Paiva et al. JOURNAL OF CLINICAL ONCOLOGY
- Improvement in Survival of Older Adults with Multiple Myeloma: Results of an Updated Period Analysis of SEER Data
- (2011) D. Pulte et al. ONCOLOGIST
- Multiple myeloma – current issues and controversies
- (2010) Shaji Kumar CANCER TREATMENT REVIEWS
- Recommendations for the validation of flow cytometric testing during drug development: II assays
- (2010) Denise M. O'Hara et al. JOURNAL OF IMMUNOLOGICAL METHODS
- The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patients
- (2009) B. Paiva et al. BLOOD
- Expected long-term survival of patients diagnosed with multiple myeloma in 2006-2010
- (2009) H. Brenner et al. HAEMATOLOGICA
- Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation
- (2008) B. Paiva et al. BLOOD
- Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders
- (2008) A. C. Rawstron et al. HAEMATOLOGICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now